Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 27, 2013 - Issue 22
220
Views
20
CrossRef citations to date
0
Altmetric
Short Communication

Antidepressant, anxiolytic and adaptogenic activity of torvanol A: an isoflavonoid from seeds of Solanum torvum

, , &
Pages 2140-2143 | Received 27 Oct 2011, Accepted 05 Feb 2013, Published online: 22 Mar 2013
 

Abstract

The objective of this study was to determine the effect of torvanol A (10 and 30 mg/kg) isolated from Solanum torvum as antidepressant, anxiolytic and adaptogenic. Forced swim test (FST), tail suspension test (TST), elevated plus maze (EPM) test, light dark apparatus (LDA), pentylenetetrazole-induced convulsions model and chronic stress-induced behavioural despair test were used. Torvanol A significantly (p < 0.05) decreased the immobility period, increased the time spent in open arms and entries in open arms, decreased the time spent in closed arms, increased the time spent in light area and decreased the time spent in dark area. Combination of torvanol A with various antagonists – prazocin(62.5 μg/kg, i.p.), para chloro phenyl alanine (pCPA) (100 mg/kg, i.p.) and haloperidol (50 μg/kg, i.p.) – has also produced the same effect in various behavioural parameters in FST, TST, EPM and LDA as the respective antagonists. This suggests involvement of noradrenergic, dopaminergic, serotonergic and gabaergic mechanisms.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.